Detalhe da pesquisa
1.
Antigiardial and antiamebic activities of fexinidazole and its metabolites: new drug leads for giardiasis and amebiasis.
Antimicrob Agents Chemother
; 68(1): e0073123, 2024 Jan 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38063401
2.
Giardia intestinalis thymidine kinase is a high-affinity enzyme crucial for DNA synthesis and an exploitable target for drug discovery.
J Biol Chem
; 298(6): 102028, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35568200
3.
The nucleolus of Giardia and its ribosomal biogenesis.
Parasitol Res
; 122(9): 1961-1971, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37400534
4.
Nitazoxanide Inhibits the Bifunctional Enzyme GlG6PD::6PGL of Giardia lamblia: Biochemical and In Silico Characterization of a New Druggable Target.
Int J Mol Sci
; 24(14)2023 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37511272
5.
Enhancing Giardicidal Activity and Aqueous Solubility through the Development of "RetroABZ", a Regioisomer of Albendazole: In Vitro, In Vivo, and In Silico Studies.
Int J Mol Sci
; 24(19)2023 Oct 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37834396
6.
Quinacrine Treatment of Nitroimidazole-Refractory Giardiasis.
J Infect Dis
; 225(10): 1773-1776, 2022 05 16.
Artigo
Inglês
| MEDLINE | ID: mdl-34036328
7.
Repurposing the Kinase Inhibitor Mavelertinib for Giardiasis Therapy.
Antimicrob Agents Chemother
; 66(7): e0001722, 2022 07 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35703552
8.
Evaluation of the efficacy of gold nanoparticles on Giardia lamblia infection in experimental animals.
Exp Parasitol
; 238: 108277, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35613683
9.
Giardia lamblia G6PD::6PGL Fused Protein Inhibitors Decrease Trophozoite Viability: A New Alternative against Giardiasis.
Int J Mol Sci
; 23(22)2022 Nov 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36430836
10.
Efficacy and Tolerability of Quinacrine Monotherapy and Albendazole Plus Chloroquine Combination Therapy in Nitroimidazole-Refractory Giardiasis: A TropNet Study.
Clin Infect Dis
; 73(8): 1517-1523, 2021 10 20.
Artigo
Inglês
| MEDLINE | ID: mdl-34115100
11.
Saccharomyces boulardii as therapeutic alternative in experimental giardiasis.
J Appl Microbiol
; 131(1): 460-469, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33289232
12.
'de Novo' repurposing of Daflon as anti-intestinal parasitic drug in experimental giardiasis.
Exp Parasitol
; 226-227: 108124, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34139241
13.
Effect of dexamethasone on experimental enteritis produced by Giardia lamblia in a Meriones unguiculatus model.
Exp Parasitol
; 230: 108158, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34534534
14.
Multilevel Approach for the Treatment of Giardiasis by Targeting Arginine Deiminase.
Int J Mol Sci
; 22(17)2021 Aug 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34502400
15.
Discovery and Preclinical Development of Antigiardiasis Fumagillol Derivatives.
Antimicrob Agents Chemother
; 64(10)2020 09 21.
Artigo
Inglês
| MEDLINE | ID: mdl-32778548
16.
Giardiasis treatment: an update with a focus on refractory disease.
Curr Opin Infect Dis
; 33(5): 355-364, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32773501
17.
Methionyl-tRNA synthetase inhibitor has potent in vivo activity in a novel Giardia lamblia luciferase murine infection model.
J Antimicrob Chemother
; 75(5): 1218-1227, 2020 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32011682
18.
Triazoxins: Novel nucleosides with anti-Giardia activity.
Bioorg Med Chem Lett
; 30(12): 127175, 2020 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32327222
19.
Ascorbic acid potentiates the Giardia duodenalis growth inhibitory activity of pure Terminalia ferdinandiana Exell compounds.
Parasitol Res
; 119(3): 1125-1137, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-31907666
20.
Metronidazole and Secnidazole Carbamates: Synthesis, Antiprotozoal Activity, and Molecular Dynamics Studies.
Molecules
; 25(4)2020 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32059495